bovin
coronavirus
bcov
isol
japan
consist
four
genet
group
determin
phylogenet
analysi
use
polymorph
region
aa
glycoprotein
gene
japanes
field
isol
bcov
refer
kakegawa
strain
vaccin
strain
analyz
antigen
properti
indirect
immunofluoresc
neutral
test
signific
differ
observ
among
bcov
direct
immunofluoresc
test
howev
antigen
differ
observ
bcov
neutral
test
although
clear
indic
distinct
serotyp
monoclon
antibodi
kakegawa
strain
belong
group
lack
signific
neutral
activ
virus
group
therefor
specul
genet
differ
group
may
alter
antigen
analysi
mutant
virus
resist
neutral
reveal
antigen
site
kakegawa
strain
map
amino
acid
posit
glycoprotein
site
homolog
known
antigen
site
aa
quebec
strain
belong
group
locat
conform
domain
compris
domain
aa
domain
ii
aa
amino
acid
constitut
neutral
epitop
bcov
distinct
aa
quebec
strain
result
indic
antigen
evolut
bcov
genet
group
circul
japan
bovin
coronaviru
bcov
infect
respiratori
intestin
tract
cattl
three
type
clinic
symptom
occur
cattl
infect
bcov
calf
diarrhea
cd
diarrhea
adult
cattl
call
winter
dysenteri
wd
respiratori
symptom
includ
ship
fever
feedlot
cattl
bcov
member
order
nidoviral
famili
coronavirida
subfamili
coronavirina
genu
betacoronaviru
speci
betacoronaviru
along
human
coronaviru
porcin
hemagglutin
encephalomyel
viru
phev
equin
coronaviru
ecov
bcov
possess
singlestrand
positivesens
nonseg
rna
genom
kb
length
virion
contain
five
structur
protein
nucleocapsid
n
protein
transmembran
protein
spike
protein
small
envelop
e
protein
hemagglutininesteras
protein
specif
member
genu
betacoronaviru
among
protein
glycoprotein
coronaviru
form
larg
petalshap
spike
surfac
virion
respons
viral
bind
hostcel
receptor
induct
neutral
antibodi
hemagglutin
activ
sequenc
glycoprotein
variabl
mutat
region
associ
alter
antigen
viral
pathogen
bcov
infect
occur
mani
countri
high
preval
countri
cow
kept
livestock
howev
knowledg
molecular
epidemiolog
analysi
among
epidem
bcov
report
except
report
canada
genet
analysi
among
domest
epidem
bcov
report
recent
unit
state
korea
denmark
brazil
report
nationwid
genet
antigen
analysi
bcov
japan
recent
attempt
clarifi
correl
among
epidem
virus
japan
isol
virus
fece
nasal
discharg
cattl
bcov
infect
analyz
gene
comparison
use
polymorph
region
aa
gene
compar
isol
causal
virus
prefectur
isol
period
strain
isol
first
infect
case
occur
kakegawa
strain
vaccin
strain
foreign
strain
regist
databas
phylogenet
analysi
polymorph
region
gene
group
strain
four
cluster
name
group
group
includ
kakegawa
vaccin
strain
foreign
strain
identifi
epidem
virus
japan
belong
group
predomin
group
chang
group
virus
group
isol
sinc
region
differ
year
incid
group
reveal
sinc
group
predomin
lineag
widespread
throughout
japan
although
bcov
thought
one
serotyp
antigen
pathogen
may
vari
among
cluster
therefor
compar
analysi
antigen
pathogen
among
cluster
conduct
undertak
prevent
measur
diseas
herein
report
result
compar
analysi
antigen
among
bovin
coronavirus
belong
distinct
group
determin
phylogenet
analysi
furthermor
identifi
locat
neutral
antigen
site
bcov
use
neutral
monoclon
antibodi
mab
neutralizationresist
mutant
hyperimmun
antisera
kakegawa
group
vaccin
strain
hokkaido
strain
prepar
rabbit
japanes
white
rabbit
virus
except
kakegawa
use
low
passag
number
passag
increas
viral
passag
cycl
cell
cultur
may
affect
antigen
composit
viru
eight
viru
strain
propag
human
rectal
tumor
cell
concentr
ultracentrifug
rabbit
inocul
subcutan
interv
week
concentr
purifi
viru
strain
emulsifi
mixtur
freund
complet
adjuv
incomplet
adjuv
rabbit
bled
serum
collect
week
final
inocul
antigen
group
bcov
examin
indirect
immunofluoresc
test
cell
monolay
grown
labtek
ii
chamber
slide
thermo
fisher
scientif
kk
yokohama
japan
fix
aceton
day
viru
inocul
rabbit
sera
viru
dilut
incub
cell
detect
phase
fluorescein
isothiocyan
fitc
conjug
goat
antirabbit
iga
igg
igm
h
l
serum
cappel
cooper
biomed
inc
malvern
pa
usa
use
neutral
antigen
virus
group
examin
use
viru
neutral
vn
test
briefli
twofold
serial
dilut
rabbit
sera
viru
react
duplic
one
hundr
tissu
cultur
infect
dose
tcid
viru
follow
incub
h
incub
serumviru
mixtur
transfer
onto
monolay
cell
cultur
micropl
incub
day
neutral
antibodi
titer
express
reciproc
highest
serum
dilut
complet
inhibit
cytopath
effect
cpe
antigen
relationship
r
strain
calcul
use
follow
formula
heterolog
titer
strain
homolog
titer
strain
heterolog
titer
strain
homolog
titer
strain
elucid
antigen
recent
predomin
group
japan
vn
test
conduct
bovin
sera
obtain
experiment
infect
use
kumamoto
viru
inoculum
brief
fivemonthold
cattl
inocul
oral
ticd
ml
viru
ml
tissu
cultur
fluid
blood
collect
inocul
neutral
antibodi
titer
virus
group
examin
neutral
test
use
mab
virus
group
neutral
mab
kakegawa
describ
sato
et
al
neutral
antibodi
titer
virus
group
supernat
hybridoma
cultur
ascit
mice
examin
vn
test
describ
bcov
kakegawa
strain
purifi
ultracentrifug
resuspend
sampl
buffer
without
boil
min
viral
protein
fraction
sdspage
protein
transfer
immunblot
pvdf
membran
biorad
laboratori
tokyo
japan
electroblot
v
min
trisglycinemethanol
buffer
describ
bjerrum
shafernielsen
block
reaction
perform
skim
milk
pb
contain
pbst
room
temperatur
overnight
membran
incub
dilut
ascit
fluid
pbst
h
room
temperatur
next
membran
wash
four
time
pbst
incub
dilut
ecl
antimous
igg
hrpo
ge
healthcar
tokyo
japan
h
room
temperatur
wash
describ
membran
develop
reaction
substrat
ecl
plu
western
blot
detect
system
ge
healthcar
visual
autoradiographi
neutralizationresist
mutant
gener
use
hybridoma
supernat
tenfold
serial
dilut
kakegawa
strain
made
tissu
cultur
plate
sampl
mix
equal
volum
hybridoma
supernat
dilut
contain
excess
antibodi
endpoint
titer
determin
plaqu
reduct
neutral
test
incub
h
cell
ad
plate
maintain
day
well
select
highest
dilut
result
viral
growth
mutant
viru
plaquepurifi
twice
rtpcr
cdna
sequenc
escap
mutant
revers
transcript
polymeras
chain
reaction
rtpcr
perform
amplifi
fulllength
cdna
gene
escap
mutant
next
rna
extract
viru
cultur
use
high
pure
viral
rna
kit
roch
diagnost
kk
tokyo
japan
oligonucleotid
primer
use
rtpcr
design
nucleotid
sequenc
kakegawa
strain
genbank
access
primer
nt
sens
primer
start
posit
gene
nt
antisens
primer
start
posit
gene
rtpcr
perform
use
titan
one
tube
rtpcr
kit
roch
diagnost
kk
follow
purif
amplifi
dna
fragment
use
qiaquick
pcr
purif
kit
qiagen
tokyo
japan
amplif
fragment
kb
length
subsequ
use
sequenc
sequenc
reaction
perform
use
bigdy
termin
v
cycl
sequenc
kit
life
technolog
tokyo
japan
sequenc
primer
design
base
sequenc
kakegawa
strain
addit
sequenc
detail
tabl
sequenc
perform
use
genet
analyz
life
technolog
anim
care
use
committe
nation
institut
anim
health
approv
anim
procedur
prior
initi
studi
hyperimmun
rabbit
sera
kakegawa
strain
react
virus
indirect
immunofluoresc
test
data
shown
viru
strain
kakegawa
hokkaido
compar
neutral
antigen
crossneutr
studi
use
antisera
virus
tabl
antisera
neutral
heterolog
strain
wherea
certain
antigen
differ
observ
among
group
particular
antisera
classic
strain
kakegawa
belong
group
show
lower
r
valu
compar
virus
belong
recent
predomin
group
group
bovin
inocul
strain
show
seroconvers
four
group
virus
tabl
howev
compar
antisera
homolog
viru
neutral
antibodi
titer
fourfold
lower
group
virus
day
inocul
respect
neutral
antibodi
titer
supernat
hybridoma
cultur
ascit
mice
virus
group
examin
vn
test
mab
neutral
homolog
strain
kakegawa
strain
belong
group
antibodi
titer
group
significantli
reduc
tabl
identifi
viral
protein
recogn
mab
bind
western
blot
assay
examin
assay
show
absenc
mab
bound
protein
identifi
subunit
protein
presenc
mab
bind
antigen
fig
harvest
virus
plaquepurifi
mutant
obtain
sequenc
gene
show
mutant
possess
singl
nucleotid
substitut
c
posit
gene
compar
kakegawa
strain
substitut
result
chang
singl
codon
valin
alanin
amino
acid
posit
protein
result
phylogenet
analysi
use
polymorph
region
aa
gene
bcov
japanes
bcov
isol
refer
strain
mebu
quebec
kakegawa
demonstr
virus
cluster
four
group
previou
studi
reveal
group
predomin
lineag
widespread
throughout
japan
sinc
although
recent
isol
still
cluster
group
data
shown
novel
group
certain
aris
near
futur
due
progress
genet
diverg
polymorph
region
gene
although
bcov
thought
one
serotyp
antigen
may
vari
among
sever
genet
group
thu
conduct
compar
analysi
antigen
among
isol
belong
group
substanti
differ
observ
among
isol
indirect
immunofluoresc
test
howev
crossvn
test
uncov
antigen
differ
among
group
although
clear
indic
distinct
serotyp
particular
mark
differ
group
suggest
genet
differ
group
may
alter
antigen
minor
antigen
differ
vn
test
result
observ
among
bcov
isol
unit
state
japan
furthermor
canadian
isol
collect
classifi
three
antigen
subgroup
basi
reactiv
panel
mab
hemagglutinationinhibit
hi
activ
sera
mebu
also
reveal
antigen
differ
field
isol
unit
state
classifi
three
subgroup
serolog
diagnosi
bcov
refer
strain
mebu
kakegawa
use
hemagglutin
inhibit
hi
test
vn
test
howev
consid
antigen
continu
chang
may
appropri
use
strain
inde
compar
antisera
homolog
viru
bovin
sera
inocul
viru
show
fourfold
reduct
vn
antibodi
titer
kakegawa
day
inocul
respect
tabl
furthermor
antigen
differ
exist
even
within
group
strain
tabl
brief
antigen
relationship
r
among
four
strain
allow
divid
two
group
result
suggest
antigen
may
vari
even
within
genet
group
neutral
antigen
site
may
exist
region
polymorph
region
use
phylogenet
studi
immunoblot
studi
mab
bound
subunit
protein
absenc
therebi
fig
neutralizationresist
mutant
gener
cocultur
possess
singl
nucleotid
substitut
posit
gene
compar
sequenc
kakegawa
strain
genbank
access
result
alter
protein
amino
acid
posit
valin
alanin
yoo
et
al
report
mab
quebec
strain
belong
group
recogn
conform
domain
consist
domain
aa
domain
ii
aa
analysi
use
neutralizationresist
mutant
reveal
neutral
antigen
site
aa
protein
polymorph
region
antigen
site
aa
studi
locat
polymorph
region
aa
domain
ii
therefor
suggest
amino
acid
constitut
altern
neutral
epitop
compar
aa
quebec
strain
howev
strain
resist
possess
valin
aa
equival
kakegawa
strain
observ
suggest
virus
amino
acid
alter
altern
site
consist
neutral
epitop
aa
alter
might
affect
reactiv
japan
monoval
inactiv
vaccin
adult
cattl
calv
administ
twice
onemonth
interv
combin
inactiv
vaccin
includ
three
type
rotaviru
escherichia
coli
adult
cattl
administ
half
month
deliveri
use
prevent
develop
calf
diseas
colostrum
unit
state
modifi
live
vaccin
combin
rotaviru
avail
addit
inactiv
vaccin
howev
prevent
effect
vaccin
uncertain
sinc
bcov
infect
replic
intestin
respiratori
mucosa
vital
induc
mucos
immun
optim
protect
aforement
vaccin
may
expect
induc
antibodi
blood
although
quantiti
circul
intestin
tract
time
inadequ
prevent
infect
replic
viru
therefor
aim
vaccin
bcov
prevent
sever
diseas
requir
treatment
reduct
weight
gain
infect
anim
object
may
accomplish
select
optim
viral
strain
whose
antigen
close
epidem
strain
well
vaccin
program
furthermor
bcov
caus
three
type
clinic
symptom
includ
cd
wd
respiratori
symptom
although
yet
appar
whether
exist
certain
genet
marker
correl
presenc
differ
clinic
symptom
futur
import
use
viral
strain
vaccin
protect
distinct
clinic
symptom
consequ
signific
task
conduct
compar
analysi
antigen
field
isol
countri
well
phylogenet
studi
provid
us
necessari
epidemiolog
inform
bcov
fig
western
blot
purifi
bcov
strain
kakegawa
use
mab
virus
purifi
resuspend
sampl
buffer
without
sdspage
transfer
pvdf
membran
bind
western
blot
assay
analyz
